Novartis AG:企業の戦略・SWOT・財務情報

◆英語タイトル:Novartis AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4424
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:74
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Novartis AG – Strategy, SWOT and Corporate Finance Report
Summary

Novartis AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Novartis AG (Novartis or ‘the company’) is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is involved in the research, development, manufacture and marketing of medicines, eye care products and generic pharmaceuticals. In addition, it offers these products to treat cancer, cardiovascular, dermatological, neurological, ophthalmic, respiratory and infectious diseases, and immune disorders.It also conducts various research and development activities through its Novartis Institutes for BioMedical Research (NIBR). Novartis is headquartered in Basel, Switzerland.

Scope

- Detailed information on Novartis AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
- An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
- Intelligence on Novartis AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novartis AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Novartis AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novartis AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Novartis AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Novartis AG: Company Overview 9
Novartis AG: Overview and Key Facts 9
Novartis AG: Overview 9
Novartis AG: Key Facts 9
Novartis AG: Key Employees 11
Novartis AG: Key Employee Biographies 13
Novartis AG: Major Products and Services 22
Novartis AG: Company History 24
Novartis AG: Management Statement 38
Novartis AG: Locations and Subsidiaries 40
Novartis AG: Key Competitors 41
Novartis AG: Company Analysis 42
Novartis AG: Business Description 42
Novartis AG: SWOT Analysis 44
Novartis AG: SWOT Overview 44
Novartis AG: Strengths 44
Novartis AG: Weaknesses 45
Novartis AG: Opportunities 46
Novartis AG: Threats 47
Novartis AG: Corporate Financial Deals Activity 49
Novartis AG: Financial Deals Overview 49
Novartis AG: Targets and Partners 51
Novartis AG: Top Deals 2014 – 2018YTD* 56
Novartis AG: Advisors 57
Novartis AG: Top Legal Advisors 57
Novartis AG: Top Financial Advisors 57
Novartis AG: Mergers and Acquisitions 58
Novartis AG: Corporate Venturing 59
Novartis AG: Capital Raising 60
Novartis AG: Partnership 61
Novartis AG: Divestments 62
Novartis AG: Recent Developments 63
Novartis AG: News and Events Summary 63
Novartis AG: Contracts 67
Novartis AG: Regulatory and Legal Events 69
Novartis AG: Research & Development 69
Novartis AG: Strategy and Operations 70
Appendix 72
Contact Us 72
Methodology 72
About MarketLine 73

List of Tables
Table 1: Novartis AG: Key Facts
Table 2: Novartis AG: Key Employees
Table 3: Novartis AG: Locations and Subsidiaries
Table 4: Novartis AG: Key Competitors
Table 5: Novartis AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Novartis AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Novartis AG: M&A Average Deal Size - Value (US$m)
Table 8: Novartis AG: Targets and Partners
Table 9: Novartis AG: Top Deals 2014 - 2018YTD*
Table 10: Novartis AG: Legal Advisor Ranking by Value (US$m)
Table 11: Novartis AG: Financial Advisor Ranking by Value (US$m)
Table 12: Novartis AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Novartis AG: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Novartis AG: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Novartis AG: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Novartis AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: Novartis AG: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: Novartis AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: Novartis AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: Novartis AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 21: Novartis AG: Divestments by Geography (2014 - YTD*2018)
Table 22: Novartis AG: News and Events Summary
Table 23: Novartis AG: Contracts
Table 24: Novartis AG: Regulatory and Legal Events
Table 25: Novartis AG: Research & Development
Table 26: Novartis AG: Strategy and Operations

List of Figures
Figure 1: Novartis AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Novartis AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Novartis AG: M&A Average Deal Size - Value (US$m)
Figure 4: Novartis AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Novartis AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Novartis AG: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Novartis AG: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Novartis AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 9: Novartis AG: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 10: Novartis AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 11: Novartis AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 12: Novartis AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 13: Novartis AG: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Novartis AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Schneider Electric SE:企業の戦略・SWOT・財務情報
    Schneider Electric SE - Strategy, SWOT and Corporate Finance Report Summary Schneider Electric SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Allegra Orthopaedics Ltd (AMT):医療機器:M&Aディール及び事業提携情報
    Summary Allegra Orthopaedics Ltd (Allegra), develops, manufactures and sells prosthetic implants and related orthopedic medical devices. Its major products include adult and adolescent clavicle fixation system and pin; shoulder implants; proximal humeral plates; trauma distal radial plates and syste …
  • Foshan Electrical and Lighting Co Ltd (000541):企業の財務・戦略的SWOT分析
    Summary Foshan Electrical and Lighting Co Ltd (Foshan Lighting) is a manufacturer and marketer of lighting products and electrical equipment. The company's products include home lighting, LED lighting products, traditional lighting and fixtures, vehicle lighting products, and electrical supports. It …
  • Corus Entertainment Inc. (CJR.B):企業の財務・戦略的SWOT分析
    Corus Entertainment Inc. (CJR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Genel Energy Plc (GENL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genel Energy Plc (Genel) is an independent upstream oil and gas company. It carries out acquisition, exploration, and production operations. It has interest in Taq Taq and Tawke in the Kurdistan region. The company develops the Miran and Bina Bawi gas fields in Zagros Fold belt in the Kurdis …
  • TransAtlantic Petroleum Ltd (TAT):石油・ガス:M&Aディール及び事業提携情報
    Summary TransAtlantic Petroleum Ltd. (TransAtlantic) is an upstream energy company that acquires, develops, explores for, and produces crude oil and natural gas. It holds interests in developed and undeveloped oil and natural gas properties in Turkey and Bulgaria. The company operates onshore explor …
  • Bill & Melinda Gates Foundation:企業のM&A・事業提携・投資動向
    Bill & Melinda Gates Foundation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bill & Melinda Gates Foundation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Stavropolenergosbyt (STSB):電力:M&Aディール及び事業提携情報
    Summary Stavropolenergosbyt, a subsidiary of Novgorodskaya energosbytovaya kompaniya is an energy and power company that supplies and distributes electricity. The company provides services such as electricity distribution, energy survey, payment information, energy audit and inspection and energy sa …
  • TWi Pharmaceuticals Inc (4180)-製薬・医療分野:企業M&A・提携分析
    Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a manufacturer of high barrier generics drugs. The company’s products include donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine …
  • Blue Sky Uranium Corp. (BSK):企業の財務・戦略的SWOT分析
    Blue Sky Uranium Corp. (BSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Enel Generacion Chile SA:発電所・企業SWOT分析
    Enel Generacion Chile SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Filtronic plc:企業の戦略・SWOT・財務情報
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • The Israel Electric Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary The Israel Electric Corporation Ltd (IECL), formerly Palestine Electric Corporation Ltd. is an integrated electric utility that carries out the generation, transmission, distribution, sale and supply of electricity. The State of Israel owns around 99.85% of the company. It generates power ma …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tepha Inc-医療機器分野:企業M&A・提携分析
    Summary Tepha Inc (Tepha) is a medical device company that develops and commercializes medical device components and finished goods. The company offers products such as absorbable monofilament suture, absorbable monofilament mesh, composite mesh and absorbable surgical film. It also provides platfor …
  • Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析
    Summary Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and devel …
  • Rice University-製薬・医療分野:企業M&A・提携分析
    Summary Rice University is an educational service provider that provides graduate and undergraduate education programs and research services. The institute offers academic programs in the field of applied physics, cognitive sciences, computational science and engineering, environment, leadership, mi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆